Author:
Puig Cristina,Fernández Ana,Gandía Luis,García Antonio G.
Reference40 articles.
1. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis;Apolloni;Disease Models & Mechanisms,2014
2. Effect of sex on lifespan, disease progression, and the response to methionine sulfoximine in the SOD1G93A mouse model for ALS;Bame;Gender Medicine,2012
3. P2X7 antagonism using brilliant blue G reduces body weight loss and prolongs survival in female SOD1G93A amyotrophic lateral sclerosis mice;Bartlett;PeerJ,2017
4. The microglial ATP-gated ion channel P2X7 as a CNS drug target;Bhattacharya;Glia,2016
5. Bhattacharya, A., Wang, Q., Ao, H., Shoblock, J. R., Lord, B., Aluisio, L., et al. (2013). Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567. British Journal of Pharmacology, 170(3), 624–640. https://doi.org/10.1111/bph.12314.